Aakriti Gupta, Mahesh V Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan, Tejasav S Sehrawat, Behnood Bikdeli, Neha Ahluwalia, John C Ausiello, Elaine Y Wan, Daniel E Freedberg, Ajay J Kirtane, Sahil A Parikh, Mathew S Maurer, Anna S Nordvig, Domenico Accili, Joan M Bathon, Sumit Mohan, Kenneth A Bauer, Martin B Leon, Harlan M Krumholz, Nir Uriel, Mandeep R Mehra, Mitchell S V Elkind, Gregg W Stone, Allan Schwartz, David D Ho, John P Bilezikian, Donald W Landry
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury...
July 2020: Nature Medicine